Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Anesthesiology ; 73(1): 109-17, 1990 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2360720

RESUMO

It is now well established that the pathophysiology of the malignant hyperthermia (MH) syndrome is related to a malfunction of intracellular calcium homeostasis. Magnesium plays important roles in the basic contractile properties of muscle, and many of its actions are antagonistic to those of calcium. The aim of this study was to determine the effectiveness of magnesium sulphate to prevent the MH episode in susceptible animals and correlate this with its effects on the intracellular free calcium [( Ca2+]i). The experiments were carried out using six control (Yorkshire) and ten MH-susceptible crossbred swine (Poland China X Pietrain). After determination of resting concentrations of [Ca2+]i and [Mg2+]i, each animal was given either two iv bolus doses of 50 mg/kg or one iv bolus of 100 mg/kg of MgSO4. The resting [Ca2+]i and [Mg2+]i were determined by means of ion-selective microelectrodes. The resting [Ca2+]i in normal muscle fibers was 0.11 +/- 0.01 microM (mean +/- SEM), whereas in the MH muscles the resting [Ca2+]i was 0.36 +/- 0.01 microM. In neither group was the resting [Ca2+]i modified by MgSO4. This cumulative dose of MgSO4 (100 mg/kg) was not able to prevent the induction of an MH episode by 2% halothane. Although MgSO4 did not directly decrease [Ca2+]i, it did attenuate the increase in [Ca2+]i associated with the syndrome from 7.29 +/- 0.43 microM in untreated animals to 0.84 +/- 0.03 microM in MgSO4 pretreated swine. In addition, the limb rigidity that accompanies this increase in calcium was prevented by MgSO4 pretreatment. Baseline measurements of [Mg2+]i were not different in control and MH-susceptible muscles.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cálcio/metabolismo , Sulfato de Magnésio/uso terapêutico , Hipertermia Maligna/prevenção & controle , Músculos/efeitos dos fármacos , Animais , Cálcio/análise , Dantroleno/farmacologia , Suscetibilidade a Doenças , Espaço Extracelular/efeitos dos fármacos , Espaço Extracelular/metabolismo , Halotano/farmacologia , Sulfato de Magnésio/sangue , Sulfato de Magnésio/farmacocinética , Hipertermia Maligna/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Microeletrodos , Músculos/metabolismo , Especificidade da Espécie , Suínos
2.
Muscle Nerve ; 11(1): 82-8, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3340102

RESUMO

Malignant hyperthermia (MH) is a genetic syndrome usually initiated by exposure to volatile anesthetic agents or depolarizing neuromuscular blocking agents. We have used Ca2+-selective microelectrodes to measure in vivo the intracellular ionized calcium ([Ca2+]i) in skeletal muscle fibers of MH-susceptible swines before and during hyperthermic episodes and also after dantrolene administration. The animals were anesthetized with thiopental and fentanyl and maintained with a mixture of nitrous oxide (66%) and oxygen (34%). The malignant hyperthermic episode was triggered by exposure to halothane. Determinations of [Ca2+]i during the episode show an increase from 0.44 +/- 0.01 microM +/- SEM, n = 20) to 8.44 +/- 0.68 microM (mean +/- SEM, n = 10). Administration of dantrolene (2 mg/kg) during the hyperthermic episode reduces [Ca2+]i to 0.17 + 0.01 microM (mean +/- SEM, n = 10) and reverses the clinical symptoms. These results show that the MH episode is associated with an increase in the myoplasmic free Ca2+ concentration and that the therapeutic effect of dantrolene is related to a decrease in [Ca2+]i.


Assuntos
Cálcio/metabolismo , Hipertermia Maligna/metabolismo , Músculos/metabolismo , Animais , Dantroleno/farmacologia , Halotano/farmacologia , Hipertermia Maligna/fisiopatologia , Potenciais da Membrana/efeitos dos fármacos , Músculos/fisiopatologia , Músculos/ultraestrutura , Concentração Osmolar , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA